Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes

AIMS: This study aimed to assess plasma fibroblast growth factor 23 (FGF23) in patients with heart failure with preserved ejection fraction (HFpEF) and its relation to inflammation, renal function, clinical and imaging characteristics, exercise capacity, and prognosis. METHODS AND RESULTS: We perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanagala, Prathap, Arnold, Jayanth R., Khan, Jamal N., Singh, Anvesha, Gulsin, Gaurav S., Eltayeb, Mohamed, Gupta, Pankaj, Squire, Iain B., McCann, Gerry P., Ng, Leong L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755022/
https://www.ncbi.nlm.nih.gov/pubmed/32935918
http://dx.doi.org/10.1002/ehf2.13020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755022/
https://www.ncbi.nlm.nih.gov/pubmed/32935918
http://dx.doi.org/10.1002/ehf2.13020

Ejemplares similares